PROFILE1014_2A | R Documentation |
Kaplan-Meier digitized data from PROFILE1014, figure 2A (PMID 27022118). A reported sample size of 343 for a primary endpoint of PFS in lung cancer.
PROFILE1014_2A
A data frame of 343 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (chemo, crizotinib) | |
Solomon BJ, Cappuzzo F, Felip E, et al. Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer: Results From PROFILE 1014. J Clin Oncol 2016; 34: 2858-67.
summary(PROFILE1014_2A)
kmplot(PROFILE1014_2A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.